EDIT Stock Forecast - Editas Medicine Inc

	Editas Medicine Inc NASDAQ:EDIT	US
M	McDonald's Corp XMUN:MDO	US
	Basanite Inc OTC:BASA	US
	S&T Bancorp Inc NASDAQ:STBA	US
A	Arteria SA WSE:ARR	PL
	Flex Ltd NASDAQ:FLEX	SG
S	Sunko Ink Co Ltd TWSE:1721	TW
	Appier Group Inc OTC:APPIF	JP

Wall St Price Targets

Wall Street analysts forecast EDIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDIT is 6.27 USD with a low forecast of 1.01 USD and a high forecast of 15.75 USD.

EDIT Lowest Forecast

-66% Downside

EDIT Average Forecast

109% Upside

EDIT Highest Forecast

425% Upside

66% Downside

109% Upside

425% Upside

AC Immune SA

251% Upside

Sutro Biopharma Inc

138% Upside

First Business Financial Services Inc

15% Upside

Trade Desk Inc

13% Upside

AC Immune SA

251% Upside

Sutro Biopharma Inc

138% Upside

First Business Financial Services Inc

15% Upside

Trade Desk Inc

13% Upside

Revenue
Forecast

N/A

Past Growth

21% / Year

Estimated Growth

Estimates Accuracy

5%

Average Beat

N/A

Past Growth

21% / Year

Estimated Growth

Estimates Accuracy

5%

Average Beat

The compound annual growth rate for Revenue over the next 8 years is 21%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

4%

Average Beat

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

What are analyst estimates?

Continue EDIT Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

F • EUR

8EM

SWB • EUR

8EM

LSE • USD

0IFK

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for EDIT is 6.27 USD with a low forecast of 1.01 USD and a high forecast of 15.75 USD.

The compound annual growth rate for Revenue over the next 8 years is 21%.

Back to Top

Editas Medicine Inc
NASDAQ:EDIT

Wall St Price Targets

EDIT Price Targets Summary
Editas Medicine Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue EDIT Research

What is EDIT's stock price target?

Price Target
6.27 USD

What is the Revenue forecast for Editas Medicine Inc?

Projected CAGR
21%

Company

Help

Tools

Stocks

Editas Medicine Inc NASDAQ:EDIT

Wall St Price Targets

EDIT Price Targets Summary Editas Medicine Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue EDIT Research

What is EDIT's stock price target? Price Target 6.27 USD

What is the Revenue forecast for Editas Medicine Inc? Projected CAGR 21%

Company

Help

Tools

Stocks

Editas Medicine Inc
NASDAQ:EDIT

EDIT Price Targets Summary
Editas Medicine Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is EDIT's stock price target?

Price Target
6.27 USD

What is the Revenue forecast for Editas Medicine Inc?

Projected CAGR
21%